BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 23454741)

  • 1. Molecular determinants of drug-receptor binding kinetics.
    Pan AC; Borhani DW; Dror RO; Shaw DE
    Drug Discov Today; 2013 Jul; 18(13-14):667-73. PubMed ID: 23454741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemogenomic approaches to drug discovery: similar receptors bind similar ligands.
    Klabunde T
    Br J Pharmacol; 2007 Sep; 152(1):5-7. PubMed ID: 17533415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role and significance of unconventional hydrogen bonds in small molecule recognition by biological receptors of pharmaceutical relevance.
    Tóth G; Bowers SG; Truong AP; Probst G
    Curr Pharm Des; 2007; 13(34):3476-93. PubMed ID: 18220785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for positive allosteric modulators of biological targets.
    Groebe DR
    Drug Discov Today; 2006 Jul; 11(13-14):632-9. PubMed ID: 16793532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physics-based methods for studying protein-ligand interactions.
    Huang N; Jacobson MP
    Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontal affinity chromatography in characterizing immobilized receptors.
    Calleri E; Temporini C; Massolini G
    J Pharm Biomed Anal; 2011 Apr; 54(5):911-25. PubMed ID: 21190807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery.
    Christopoulos A
    Nat Rev Drug Discov; 2002 Mar; 1(3):198-210. PubMed ID: 12120504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles for modulation of the nuclear receptor superfamily.
    Gronemeyer H; Gustafsson JA; Laudet V
    Nat Rev Drug Discov; 2004 Nov; 3(11):950-64. PubMed ID: 15520817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Target Binding Kinetics in Drug Discovery.
    Guo D; Heitman LH; IJzerman AP
    ChemMedChem; 2015 Nov; 10(11):1793-6. PubMed ID: 26506404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical biology of steroid and nuclear hormone receptors.
    Biggins JB; Koh JT
    Curr Opin Chem Biol; 2007 Feb; 11(1):99-110. PubMed ID: 17188557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into ligand-elicited activation of human constitutive androstane receptor based on novel agonists and three-dimensional quantitative structure-activity relationship.
    Jyrkkärinne J; Windshügel B; Rönkkö T; Tervo AJ; Küblbeck J; Lahtela-Kakkonen M; Sippl W; Poso A; Honkakoski P
    J Med Chem; 2008 Nov; 51(22):7181-92. PubMed ID: 18983136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a high-affinity ligand that binds irreversibly to Mel1b melatonin receptors.
    Witt-Enderby PA; Chu GH; Gillen ML; Li PK
    J Med Chem; 1997 Dec; 40(26):4195-8. PubMed ID: 9435890
    [No Abstract]   [Full Text] [Related]  

  • 18. Pocket extraction on proteins via the Voronoi diagram of spheres.
    Kim D; Cho CH; Cho Y; Ryu J; Bhak J; Kim DS
    J Mol Graph Model; 2008 Apr; 26(7):1104-12. PubMed ID: 18023220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of the drug-binding specificity of human serum albumin.
    Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
    J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-affinity relationships of indole-based melatonin analogs.
    Spadoni G; Mor M; Tarzia G
    Biol Signals Recept; 1999; 8(1-2):15-23. PubMed ID: 10085458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.